# Use of a GLP-1R Agonist to Treat Opioid Use Disorder

> **NCT04199728** · PHASE1,PHASE2 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 27 (actual)

## Conditions studied

- Opiate Substitution Treatment
- Opioid-Related Disorders

## Interventions

- **DRUG:** Liraglutide Pen Injector
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04199728
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-18
- **Primary completion:** 2023-09-13
- **Final completion:** 2023-09-13
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-11-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04199728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04199728, "Use of a GLP-1R Agonist to Treat Opioid Use Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04199728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*